Global Etanercept Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2015-2026
- Published Date: 2020-11-29
- Report ID: 24453
- Pages: 119
-
Format:
Summary
As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%.
Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States.
In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter.
Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970.
Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. XYZResearch published a report for global Etanercept market in this environment.
In terms of revenue, this research report indicated that the global Etanercept market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. Correspondingly, the forecast analysis of Etanercept industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments.
The Amgen aims at producing XX Etanercept in 2020, with XX % production to take place in global market, Pfizer accounts for a volume share of XX %.
Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Etanercept Market by XYZResearch Include
China
EU
USA
Japan
India
Southeast Asia
South America
Competitive Analysis; Who are the Major Players in Etanercept Market
Amgen
Pfizer
Takeda
Sanofi
GlaxoSmithKline
Sandoz
Celltrion
Dexa Medica
Bionovis
Momenta Pharmaceuticals
HanAll Biopharma
MedImmune
Tsumura
...
Major Type of Etanercept Covered in XYZResearch report:
Enbrel
Benepali
Application Segments Covered in XYZResearch Market
Rheumatoid arthritis
Psoriatic arthritis
Ankylosing spondylitis
Juvenile idiopathic arthritis (JIA)
Others
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global Etanercept Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Enbrel -Product Introduction and Major Manufacturers
1.1.2 Benepali -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Global Etanercept Market Assessment, by Segmentation
2.1 Type Breakdown Estimates & Forecast, Sales Volume (2015-2026)
2.2 Type Breakdown Estimates & Forecast, Sales Value (2015-2026)
2.3 Application Breakdown Estimates & Forecast, by Application (2015-2026)
3 Regional Market Analysis
3.1 China Etanercept Market
3.1.1 Top Companies leading Etanercept Development in China (2015-2020)
3.1.2 Sales Value of Major Company in China Market (2015-2020)
3.1.3 China Etanercept Price (USD/Unit), by Type (2019-2020)
3.1.4 Sales in China Market, by Type (2015-2026)
3.2 EU Etanercept Market
3.2.1 Top Companies leading Etanercept Development in EU (2015-2020)
3.2.2 Sales Value of Major Company in EU Market (2015-2020)
3.2.3 EU Etanercept Price (USD/Unit), by Type (2019-2020)
3.2.4 Sales in EU Market, by Type (2015-2026)
3.3 USA Etanercept Market
3.3.1 Top Companies leading Etanercept Development in USA (2015-2020)
3.3.2 Sales Value of Major Company in USA Market (2015-2020)
3.3.3 USA Etanercept Price (USD/Unit), by Type (2019-2020)
3.3.4 Sales in USA Market, by Type (2015-2026)
3.4 Japan Etanercept Market
3.4.1 Top Companies leading Etanercept Development in Japan (2015-2020)
3.4.2 Sales Value of Major Company in Japan Market (2015-2020)
3.4.3 Japan Etanercept Price (USD/Unit), by Type (2019-2020)
3.4.4 Sales in Japan Market, by Type (2015-2026)
3.5 India Etanercept Market
3.5.1 Top Companies leading Etanercept Development in India (2015-2020)
3.5.2 Sales Value of Major Company in India Market (2015-2020)
3.5.3 India Etanercept Price (USD/Unit), by Type (2019-2020)
3.5.4 Sales in India Market, by Type (2015-2026)
3.6 Southeast Asia Etanercept Market
3.6.1 Top Companies leading Etanercept Development in Southeast Asia (2015-2020)
3.6.2 Sales Value of Major Company in Southeast Asia Market (2015-2020)
3.6.3 Southeast Asia Etanercept Price (USD/Unit), by Type (2019-2020)
3.6.4 Sales in Southeast Asia Market, by Type (2015-2026)
3.7 South America Etanercept Market
3.7.1 Top Companies leading Etanercept Development in South America (2015-2020)
3.7.2 Sales Value of Major Company in South America Market (2015-2020)
3.7.3 South America Etanercept Price (USD/Unit), by Type (2019-2020)
3.7.4 Sales in South America Market, by Type (2015-2026)
4 Value Chain (Impact of COVID-19)
4.1 Etanercept Value Chain Analysis
4.1.1 Upstream
4.1.2 Downstream
4.2 COVID-19 Impact on Etanercept Industry
4.2.1 Industrial Policy Issued Under the Epidemic Situation
4.3 Cost-Under the Epidemic Situation
4.3.1 Cost of Raw Material
4.4 Channel Analysis
4.4.1 Distribution Channel-Under the Epidemic Situation
4.4.2 Distributors
5 Regional Market Forecast (2021-2026)
5.1 Global Etanercept Sales and Growth Rate (2021-2026)
5.2 Global Etanercept Sales Value and Growth Rate (2021-2026)
6 Etanercept Competitive Analysis
6.1 Amgen
6.1.1 Amgen Company Profiles
6.1.2 Amgen Product Introduction
6.1.3 Amgen Etanercept Production, Revenue (2015-2020)
6.1.4 SWOT Analysis
6.2 Pfizer
6.2.1 Pfizer Company Profiles
6.2.2 Pfizer Product Introduction
6.2.3 Pfizer Etanercept Production, Revenue (2015-2020)
6.2.4 SWOT Analysis
6.3 Takeda
6.3.1 Takeda Company Profiles
6.3.2 Takeda Product Introduction
6.3.3 Takeda Etanercept Production, Revenue (2015-2020)
6.3.4 SWOT Analysis
6.4 Sanofi
6.4.1 Sanofi Company Profiles
6.4.2 Sanofi Product Introduction
6.4.3 Sanofi Etanercept Production, Revenue (2015-2020)
6.4.4 SWOT Analysis
6.5 GlaxoSmithKline
6.5.1 GlaxoSmithKline Company Profiles
6.5.2 GlaxoSmithKline Product Introduction
6.5.3 GlaxoSmithKline Etanercept Production, Revenue (2015-2020)
6.5.4 SWOT Analysis
6.6 Sandoz
6.6.1 Sandoz Company Profiles
6.6.2 Sandoz Product Introduction
6.6.3 Sandoz Etanercept Production, Revenue (2015-2020)
6.6.4 SWOT Analysis
6.7 Celltrion
6.7.1 Celltrion Company Profiles
6.7.2 Celltrion Product Introduction
6.7.3 Celltrion Etanercept Production, Revenue (2015-2020)
6.7.4 SWOT Analysis
6.8 Dexa Medica
6.8.1 Dexa Medica Company Profiles
6.8.2 Dexa Medica Product Introduction
6.8.3 Dexa Medica Etanercept Production, Revenue (2015-2020)
6.8.4 SWOT Analysis
6.9 Bionovis
6.9.1 Bionovis Company Profiles
6.9.2 Bionovis Product Introduction
6.9.3 Bionovis Etanercept Production, Revenue (2015-2020)
6.9.4 SWOT Analysis
6.10 Momenta Pharmaceuticals
6.10.1 Momenta Pharmaceuticals Company Profiles
6.10.2 Momenta Pharmaceuticals Product Introduction
6.10.3 Momenta Pharmaceuticals Etanercept Production, Revenue (2015-2020)
6.10.4 SWOT Analysis
6.11 HanAll Biopharma
6.12 MedImmune
6.13 Tsumura
7 Conclusion
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
